Wells Fargo & Company Teva Pharmaceutical Industries LTD Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Wells Fargo & Company holds 925,219 shares of TEVA stock, worth $14.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

925,219

Previous 291,560 217.33%

Holding current value

$14.6 Million

Previous $3.04 Million 328.98%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$10.67 - $14.43 $6.76 Million - $9.14 Million	633,659 Added 217.33%	925,219 $13.1 Million
Q4 2023 Feb 09, 2024	SELL	$8.12 - $10.63 $169,480 - $221,869	-20,872 Reduced 6.68%	291,560 $3.04 Million
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $90,605 - $129,609	12,113 Added 4.03%	312,432 $3.19 Million
Q2 2023 Aug 15, 2023	SELL	$7.2 - $9.47 $1.22 Million - $1.6 Million	-169,034 Reduced 36.01%	300,319 $2.26 Million
Q1 2023 May 12, 2023	SELL	$8.36 - $11.37 $1.13 Million - $1.53 Million	-134,623 Reduced 22.29%	469,353 $4.15 Million

Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $1.95 Million - $2.33 Million	245,749 Added 68.6%	603,976 $5.51 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $250,088 - $435,649	-36,456 Reduced 9.24%	358,227 $2.89 Million
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $645,218 - $909,251	87,428 Added 28.45%	394,683 $2.97 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $272,199 - $348,697	-37,135 Reduced 10.78%	307,255 $2.89 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $119,155 - $153,695	15,083 Added 4.58%	344,390 $2.76 Million
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $2.16 Million - $2.62 Million	-257,635 Reduced 43.89%	329,307 $3.21 Million
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $1.48 Million - $1.73 Million	149,407 Added 34.15%	586,942 $5.81 Million
Q1 2021 May 13, 2021	BUY	$10.34 - $12.81 $568,245 - $703,986	54,956 Added 14.36%	437,535 $5.05 Million
Q4 2020 Feb 09, 2021	SELL	$8.61 - $11.04 $820,395 - $1.05 Million	-95,284 Reduced 19.94%	382,579 $3.69 Million
Q3 2020 Nov 05, 2020	SELL	$8.57 - $12.69 $569,545 - $843,352	-66,458 Reduced 12.21%	477,863 $4.31 Million
Q2 2020 Aug 13, 2020	SELL	$8.12 - $13.12 $4.7 Million - $7.6 Million	-579,264 Reduced 51.55%	544,321 $6.71 Million
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $7.52 Million - $15.1 Million	1,123,585 New	1,123,585 $10.1 Million

Others Institutions Holding TEVA

# of Institutions

543

Shares Held

548M

Call Options Held

19.8M

Put Options Held

14M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $17.6B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Teva Pharmaceutical Industries LTD Transaction History